Dr. Bahri M. Bilir, MD

Dr. Bilir practices at Arapahoe Endoscopy Center in Littleton, Colorado.

Dr. Bilir's NPI, 1649266701, was assigned on September 23, 2005. Dr. Bilir graduated from Hacettepe University FOM in 1983. Dr. Bilir holds Colorado license 32914.

Dr. Bilir's primary practice is Arapahoe Endoscopy Center, at 1001 Southpark Dr, Littleton, CO 80120. The practice phone is (720) 772-5550.

Dr. Bilir's primary practice is Arapahoe Endoscopy Center in Littleton, Colorado. Dr. Bilir is also affiliated with AdventHealth Littleton. The medical group on file is AdventHealth Transplant Institute North Billings. Dmand AI also links Dr. Bilir to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bilir practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bilir's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bilir is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bilir's licenses on file in 3 states: Colorado, Michigan and Illinois.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, fatty liver, gastrointestinal bleeding, hemorrhoids, high cholesterol and intestinal diverticulosis among the conditions Dr. Bilir treats.

CMS data shows 308 Medicare services from Dr. Bilir across 10 procedure codes in 2024, for 265 Medicare patients. Medicare paid $41,752 for them.

CMS counts 265 Medicare patients who saw Dr. Bilir in 2024. The largest group is 65 to 74, with 162 patients. 70% of them have high cholesterol, and 61% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bilir's median patient age at 62, with 50% women.

In 2024, Dr. Bilir wrote 641 Medicare Part D claims for 187 patients. 83% of them were for generic drugs. CMS names the drug for 484 of them, across 14 drugs with 11 or more claims each, at $418,618 in total drug cost. In 2023, CMS named 417 claims across 10 drugs.

Dr. Bilir accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 160 procedures of colonoscopy by Dr. Bilir, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Bilir, published from 2017 to 2025. Dr. Bilir's most frequent co-authors are Jason Lamar Aldred, MD, Alan Bonder, MD and Christopher L. Bowlus, MD.

Dmand AI links Dr. Bilir to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Cholangitis, Sclerosing and Cholangitis. Open Payments lists research payments to Dr. Bilir that name 1 trial.

CMS Open Payments shows 735 general payments to Dr. Bilir from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $3,562. It also lists 3 research payments totaling $17,200 in 2023, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Bilir, most recently CMS Stage 1 2012 in 2011.

Dr. Bilir graduated from Hacettepe University FOM in 1983. Dr. Bilir is a member of ACP.

Dr. Bilir is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.